Pharma Deals - Pharmaceutical Technology Dashboard
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Knowledge of deal activity is critical to understanding the performance and future direction of the pharmaceutical industry and the prospects for pharmaceutical companies. The Pharmaceutical Technology deals dashboard gives business professionals detailed insights into merger and acquisition activity, private equity deals and venture investments. The dashboard also tracks the top financial advisors and legal advisors supporting pharma deals.

Pharma Sector All Deal Activity by Value and Volume (Last 12 months)

Pharma Sector Overall Deal Activity by Region (Last 12 months)

Source: GlobalData Deals Database

Top Deals in Pharma Sector (Last 12 months)

Acquirer/Investor Issuer / Partner / Target Deal Date Value (US$m)
AstraZeneca Alexion Pharmaceuticals 12 Dec 2020 39,000.0
The Carlyle Group ., The Blackstone Group , GIC Pvt , Hellman & Friedman Medline Industries 05 Jun 2021 34,000.0
Thermo Fisher Scientific PPD 15 Apr 2021 20,900.0
Bristol-Myers Squibb MyoKardia 05 Oct 2020 13,100.0
ICON PRA Health Sciences 24 Feb 2021 12,000.0
Danaher Aldevron 17 Jun 2021 9,600.0
Undisclosed Bidder Parexel International 20 Apr 2021 9,000.0
Goldman Sachs Asset Management , EQT Partners Parexel International 02 Jul 2021 8,500.0
Agnafit Bidco Swedish Orphan Biovitrum 02 Sep 2021 8,047.6
Jazz Pharmaceuticals GW Pharmaceuticals 03 Feb 2021 7,200.0
Source: GlobalData Deals Database

Top Pharma Sector Advisors (2020 Vs. 2019)

Top Financial Advisors – All Deals

Advisor Name 2020 Rank 2019 Rank
Centerview Partners 1 9
Morgan Stanley 2 1
The Goldman Sachs Group 3 4
Bank of America Corp 4 10
JPMorgan Chase & Co 5 20
Evercore 6 3
Lazard 7 18
Ondra 8 68
Cowen 9 19
J.P. Morgan Securities 10 2
Source: GlobalData Deals Database
Advisor Name 2020 Rank 2019 Rank
Jefferies 1 8
The Goldman Sachs Group 2 2
Cowen 3 33
Centerview Partners 4 4
Bank of America Corp 5 9
SVB Financial Group 6 12
Morgan Stanley 7 1
Evercore 8 7
Rothschild & Co SCA 9 5
Barclays Plc 10 23
Source: GlobalData Deals Database

Top Legal Advisors – All Deals

Advisor Name 2020 Rank 2019 Rank
Wachtell, Lipton, Rosen & Katz 1 3
Fried, Frank, Harris, Shriver & Jacobson 2 19
Goodwin Procter 3 20
Freshfields Bruckhaus Deringer 4 16
Allen & Overy 5 62
Latham & Watkins 6 21
Simmons & Simmons 7 173
Sullivan & Cromwell 8 15
Davis Polk & Wardwell 9 2
Cravath, Swaine & Moore 10 18
Source: GlobalData Deals Database
Advisor Name 2020 Rank 2019 Rank
Goodwin Procter 1 2
Wilson Sonsini Goodrich & Rosati 2 23
Latham & Watkins 3 1
Cooley 4 5
Ropes & Gray 5 7
Kirkland & Ellis 6 4
Baker & McKenzie 7 12
Morgan, Lewis & Bockius 8 15
Jones Day 9 3
Dechert 10 54
Source: GlobalData Deals Database

Pharma Sector Mergers & Acquisitions Deal Activity by Value and Volume (Last 12 months)

Pharma Sector Mergers & Acquisitions by Region (Last 12 months)

Source: GlobalData Deals Database

Top Mergers & Acquisitions in Pharma Sector (Last 12 months)

Acquirer/Investor Issuer / Partner / Target Deal Date Value (US$m)
AstraZeneca Alexion Pharmaceuticals 12 Dec 2020 39,000.0
Thermo Fisher Scientific PPD 15 Apr 2021 20,900.0
Bristol-Myers Squibb MyoKardia 05 Oct 2020 13,100.0
ICON PRA Health Sciences 24 Feb 2021 12,000.0
Danaher Aldevron 17 Jun 2021 9,600.0
Agnafit Bidco Swedish Orphan Biovitrum 02 Sep 2021 8,047.6
Jazz Pharmaceuticals GW Pharmaceuticals 03 Feb 2021 7,200.0
Humana Kindred Healthcare 27 Apr 2021 5,700.0
PerkinElmer Biolegend 26 Jul 2021 5,250.0
CBPO Holdings China Biologic Products Holdings 19 Nov 2020 4,760.0
Source: GlobalData Deals Database

Top Pharma Sector Advisors (2020 Vs. 2019)

Top Financial Advisors - Mergers & Acquisitions Deals

Advisor Name 2020 Rank 2019 Rank
Centerview Partners 1 9
Morgan Stanley 2 1
The Goldman Sachs Group 3 4
Bank of America Corp 4 12
JPMorgan Chase & Co 5 20
Evercore 6 3
Lazard 7 15
Ondra 8 50
Cowen 9 17
Mizuho Financial Group 10 N/A
Source: GlobalData Deals Database
Advisor Name 2020 Rank 2019 Rank
Centerview Partners 1 4
The Goldman Sachs Group 2 2
Bank of America Corp 3 6
Jefferies 4 5
Lazard 5 3
Morgan Stanley 6 1
JPMorgan Chase & Co 7 23
Evercore 8 8
Cowen 9 35
Barclays Plc 10 22
Source: GlobalData Deals Database

Top Legal Advisors - Mergers & Acquisitions Deals

Advisor Name 2020 Rank 2019 Rank
Wachtell, Lipton, Rosen & Katz 1 3
Fried, Frank, Harris, Shriver & Jacobson 2 18
Goodwin Procter 3 19
Freshfields Bruckhaus Deringer 4 20
Allen & Overy 5 65
Simmons & Simmons 6 126
Sullivan & Cromwell 7 15
Latham & Watkins 8 22
Davis Polk & Wardwell 9 2
Cravath, Swaine & Moore 10 17
Source: GlobalData Deals Database
Advisor Name 2020 Rank 2019 Rank
Goodwin Procter 1 1
Cooley 2 3
Morgan, Lewis & Bockius 3 12
Latham & Watkins 4 2
Wilson Sonsini Goodrich & Rosati 5 16
White & Case 6 23
Skadden, Arps, Slate, Meagher & Flom & Affiliates 7 4
Ropes & Gray 8 15
Gibson, Dunn & Crutcher 9 22
Kirkland & Ellis 10 6
Source: GlobalData Deals Database

Pharma Sector Private Equity Deal Activity by Value and Volume (Last 12 months)

Pharma Sector Private Equity Deals by Region (Last 12 months)

Source: GlobalData Deals Database

Top Private Equity Deals in Pharma Sector (Last 12 months)

Acquirer/Investor Issuer / Partner / Target Deal Date Value (US$m)
The Carlyle Group ., The Blackstone Group , GIC Pvt , Hellman & Friedman Medline Industries 05 Jun 2021 34,000.0
Undisclosed Bidder Parexel International 20 Apr 2021 9,000.0
Goldman Sachs Asset Management , EQT Partners Parexel International 02 Jul 2021 8,500.0
Permira Advisers LivaNova 04 Mar 2021 3,700.0
CVC Capital Partners Fund VII, Avista Capital Partners (Avista Capital Holdings, ) Cooper Consumer Health 12 Mar 2021 2,600.0
EQT IX Fund Recipharm 14 Dec 2020 2,116.9
Nordic Capital Advanz Pharma 27 Jan 2021 1,920.1
Partners Group Pharmathen 19 Jul 2021 1,888.7
Altaris Capital Partners Generic Rx Pharma Business 01 Mar 2021 1,550.0
Pamplona Capital Management , Triton Investment Management Limited, CVC Capital Partners SICAV-FIS SA, Bain Capital , BC Partners Mediq 21 Oct 2020 1,416.3
Source: GlobalData Deals Database

Top Pharma Sector Advisors (2020 Vs. 2019)

Top Financial Advisors – Private Equity Deals

Advisor Name 2020 Rank 2019 Rank
Rothschild & Co SCA 1 1
Deloitte Touche Tohmatsu 2 23
Carnegie Holding AB 3 N/A
Goldman Sachs International 4 N/A
Jefferies International 5 N/A
Ernst & Young Global 6 31
PricewaterhouseCoopers International 7 2
UBS Group AG 8 3
Jefferies 9 50
Evercore 10 15
Source: GlobalData Deals Database
Advisor Name 2020 Rank 2019 Rank
Jefferies 1 51
SVB Financial Group 2 37
Rothschild & Co SCA 3 2
Carnegie Holding AB 4 N/A
Cowen 5 N/A
Deloitte Touche Tohmatsu 6 7
Evercore 7 6
Barclays Plc 8 16
Van Lanschot Kempen NV 9 N/A
Ernst & Young Global 10 9
Source: GlobalData Deals Database

Top Legal Advisors – Private Equity Deals

Advisor Name 2020 Rank 2019 Rank
Ropes & Gray 1 17
Latham & Watkins 2 10
Uria Menendez Abogados S 3 N/A
Goodwin Procter 4 28
Clifford Chance 5 41
Roschier Attorneys 6 38
Setterwalls Advokatbyra AB 7 N/A
Allen & Overy 8 56
Linklaters 9 5
Ashurst 10 7
Source: GlobalData Deals Database
Advisor Name 2020 Rank 2019 Rank
Latham & Watkins 1 1
Goodwin Procter 2 36
Ropes & Gray 3 3
Uria Menendez Abogados S 4 N/A
Baker & McKenzie 5 N/A
Kirkland & Ellis 6 2
DLA Piper 7 N/A
Sidley Austin 8 19
Dechert 9 35
Paul, Weiss, Rifkind, Wharton & Garrison 10 16
Source: GlobalData Deals Database

Pharma Sector Venture Financing Deal Activity by Value and Volume (Last 12 months)

Pharma Sector Venture Financing Deals by Region (Last 12 months)

Source: GlobalData Deals Database

Top Venture Financing Deals in Pharma Sector (Last 12 months)

Acquirer/Investor Issuer / Partner / Target Deal Date Value (US$m)
GV Management , New Enterprise Associates , 8VC, ARCH Venture Partners National Resilience 23 Nov 2020 750.0
Temasek Holdings (Private) , Lilly Asia ventures, GL Ventures Suzhou Abogen Biosciences 19 Aug 2021 700.0
Itochu Technology Ventures, ., Emerson Collective , Invus Group , EcoR1 Capital , Vertex Ventures HC, F2 Ventures Limited, Matrix Capital Management Fund , Surveyor Capital , SoftBank Vision Fund , Redmile Group , Fidelity Management & Research Company, EDBI Pte , Samsara BioCapital , MPM Capital ElevateBio 15 Mar 2021 525.0
SignalFire Management Services, , Radcliff Group, Baupost Group, FirstMark Capital , Altimeter Capital Management , TQ Ventures , General Catalyst Partners , BoxGroup, ShawSpring Partners, , Torch Capital, Dragoneer Investment Group , 776 Fund Management Ro-co 23 Mar 2021 500.0
Andreessen Horowitz , Nextech Invest , Casdin Capital , ARCH Venture Partners , Section 32, Arboretum Ventures , GV Management EQRx 11 Jan 2021 500.0
Federated Hermes , BlackRock , Flagship Pioneering , Canada Pension Plan Investment Board, Fidelity Management & Research Company, Invus , T Rowe Price Associates Laronde 30 Aug 2021 440.0
Sino Biopharmaceutical , 5Y Capital, Orbimed Advisors , Sequoia Capital Operations , RRJ Capital XtalPi 11 Aug 2021 400.0
Temasek Holdings (Private) , Two Sigma Ventures , GV Management , Alexandria Venture Investments, Foresite Capital Management , Third Rock Ventures , SoftBank Investment Advisors, BlackRock , T Rowe Price Associates , Andreessen Horowitz , ARCH Venture Partners , Canada Pension Plan Investment Board, Casdin Capital , HOF Capital Insitro 15 Mar 2021 400.0
Premji Invest, Orbimed Advisors , Population Health Partners , GV Management , Foresite Capital Management , Federated Hermes , Mithril Capital Management , Redmile Group , RA Capital Management , Polaris Partners , ArrowMark Partners, Adimab , Fidelity Management & Research Company, Omega Fund Management Adagio Therapeutics 19 Apr 2021 336.0
Central Enterprise Poverty Area Industrial Investment Fund , China Merchants Securities , Tianjin Liren Investment Management, Huatai Securities Shenzhen Huada Gene 09 Feb 2021 310.3
Source: GlobalData Deals Database

All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.

Latest News

View More